-+ 0.00%
-+ 0.00%
-+ 0.00%

DNA X grants acting CEO Mike Mulica cash award in lieu of annual stock units

PUBT·11/16/2026 21:49:37
Listen to the news
DNA X grants acting CEO Mike Mulica cash award in lieu of annual stock units
  • DNA X approved a cash award for acting CEO and Executive Chairman Mike Mulica on November 14, 2026.
  • The award is based on Phantom restricted stock units initially valued at $50,000 using the stock’s fair market value on that date.
  • The payout will equal the Phantom RSU count multiplied by the stock’s fair market value at vesting.
  • Vesting occurs at the earlier of the 2027 annual stockholder meeting or a change in control.
  • Payment is due at vesting, subject to Mulica’s continued service through that event.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DNA X Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-052460), on November 16, 2026, and is solely responsible for the information contained therein.